Aldeyra Raises Additional Capital To Fund Dry Eye Treatment
September 27, 2017 at 12:55 PM EDT
ALDX recently raised nearly $27MM to fund its dry eye treatment. Fresh capital gives ALDX flexibility to partner with big pharma for drug development or go it alone. The dry eye market offers huge upside for a new entrant. ALDX is a buy.